IP Library Granted Patent US 9,006,460
Granted Patent B2
US 9,006,460 · App. 13/817,274 · Granted Apr 14, 2015

Process for preparing aminocyclohexyl ether compounds

Inventors: John Limanto (Rahway, NJ); Gregory L. Beutner (Green Brook, NJ); Jingjun Yin (Green Brook, NJ); Artis Klapars (Edison, NJ); Eric R. Ashley (Fanwood, NJ); Hallena R. Strotman (Somerset, NJ); Matthew D. Truppo (Bradley Beach, NJ); Cheol K. Chung (Westfield, NJ); Gregory Hughes (Scotch Plains, NJ); Zhijian Liu (Kendall Park, NJ); Brendan Grau (Warrington, NJ); Jacob Janey (New York, NY)
Assignee: Cardiome International AG
C12P17/10C07D207/12
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,006,460
App. No.
13/817,274
Granted
Apr 14, 2015
Kind
B2
Abstract

The present invention relates to a process for preparing aminocyclohexyl ether compounds of Formula I: or the pharmaceutically acceptable salts and esters thereof. In particular, the instant invention is directed towards a process for preparing (1R,2R)-2-[(3R)-Hydroxypyrrolidinyl]-1-(3,4-dimethoxyphenethoxy)-cyclohexane as well as various intermediates.

Claims (129)

1. A process for preparing compounds of Formula I:

where Y is selected from 3,4-dimethoxyphenyl, 3,4-dihydroxyphenyl or a 3,4-dihalophenyl, comprising the steps of:

a) Mixing a cyclohexyl amine (iv)

 with a malic acid derivative (v)

 where R 2 is selected from hydrogen, esters, carbonates, carbamates, silyl ethers, phosphates or sulfates and where X and Z are independently selected from OH, C 1 -C 6 alkoxy, esters, halides or O-acyl, said X and Z may ontionally be ioined to form a ring (v-a)

to obtain a hydroxy succinimide (vi)

b) isolating the hydroxy succinimide (vi) to provide an isolated hydroxy succinimide (vi); and

c) reducing the isolated hydroxy succinimide (vi) to obtain a compound of Formula I.

2. The process of claim 1 comprising the steps of:

a) mixing an alkoxy ketone (iii)

 where Y is selected from 3,4-dimethoxyphenyl, 3,4-dihydroxyphenyl or a 3 , 4 -dihalophenyl, with a co-factor, a transaminase polypeptide and an amine to produce a cyclohexyl amine (iv)

b) mixing the cyclohexyl amine (iv) with a malic acid derivative (v)

where R 2 is selected from hydrogen, esters, carbonates, carbamates, silyl ethers, phosphates or sulfates, and where X and Z are independently selected from OH, C 1 -C 6 alkoxy, esters, halides or O-acyl, said X and Z may optionally be joined to form a ring (v-a)

to obtain a hydroxy succinimide (vi)

and

c) reducing the isolated hydroxy succinimide (vi) to obtain a compound of Formula I.

3. The process of claim 1 comprising the steps of:

a) mixing a substituted cycloalkanone (i)

 where R 1 is an activated leaving group and integer n is selected from 1, 2, or 3

b) with a substituted ethanol (ii)

 where Y is selected from 3,4-dimethoxyphenyl, 3,4-dihydroxyphenyl or a 3,4-dihalophenyl, in the presence of a metal salt and an organic base to form a cycloalkanone of structure

 where when n is 1 the cycloalkanone is ring expanded and when n is 3 the cycloalkanone is ring contacted, to provide an alkoxy ketone (iii)

c) mixing the alkoxy ketone (iii) with a co-factor, a transaminase polypeptide and an amine to produce a cyclohexyl amine (iv)

d) mixing the cyclohexyl amine (iv) with a malic acid derivative (v)

where R 2 is selected from hydrogen, esters, carbonates, carbamates, silyl ethers, phosphates or sulfates, and where X and Z are independently selected from OH, C1-C6 alkoxy, esters, halides or O-acyl, said X and Z may optionally be ioined to form a ring (v-a)

to obtain a hydroxy succinimide (vi)

and

e) reducing the isolated hydroxy succinimide (vi) to obtain a compound of Formula I.

4. The process of claim 3 which further comprises in step b) mixing the alkoxy ketone (iii) with the co-factor, and a slurry containing the transaminase polypeptide in a basic buffer and an amine.

5. The process of claim 4 , which further comprises adding an acid activator to step c.

6. The process of claim 5 , which further comprises adding a metal hydride to the hydroxy succinimide (vi) to obtain a compound of Formula I.

7. The process of claim 1 , comprising the steps of:

a) Mixing a substituted ethanol (ii)

 where Y is selected from 3,4-dimethoxyphenyl, 3,4-dihydroxyphenyl or a 3,4-dihalophenyl, with a zinc salt, a secondary amine and an organic base in a first solvent;

b) Adding a solution of a substituted cycloalkanone (i)

 where R 1 is an activated leaving group and integer n is 2, to obtain a mixture;

c) Heating the mixture to about 60 to about 150° C. and then cooling the mixture to less than about 60° C.;

d) Adding an acidic aqueous solution to create a biphasic mixture and discarding the aqueous phase;

e) Adding a second solvent to obtain an alkoxy ketone (iii)

f) Mixing a co-factor with a slurry of a transaminase polypeptide in a basic buffer and a primary amine to produce a solution;

g) Adding the alkoxy ketone (iii) in a second solvent to the solution of step f);

h) Adding a third solvent to create a biphasic mixture and discarding the aqueous layer;

i) Washing the organic layer from step h) with a basic aqueous solution and discarding the aqueous layer;

j) Performing a solvent switch from the third solvent to a fourth solvent;

k) Adding an acid to create a slurry;

l) Filtering the slurry to obtain cyclohexyl amine salt (iv-a);

m) Adding the cyclohexyl amine salt (iv-a) to a mixture of a first solvent and a basic aqueous solution and discarding the aqueous layer;

n) Adding a malic acid derivative, which is selected from malic acid or (v-a)

 in a first solvent to the cyclohexyl amine (iv-a) in a first solvent;

o) Adding an acid activator;

p) Adding a fourth solvent to obtain hydroxy succinimide (vi)

q) Mixing a metal hydride, an additive and an acid, which is selected from a Lewis acid or a protic acid, with a solution of the isolated hydroxy succinimide (vi);

r) Adding a fifth solvent and a basic aqueous solution to obtain a biphasic mixture and discarding the aqueous layer to obtain Compound A

 and

s) Adding an acid to obtain the salt of Compound A.

8. The process of claim 1 , where a transaminase polypeptide having an amino acid sequence of SEQ ID NO: 18 or SEQ ID NO: 206 is used.

9. The process of claim 1 , where a transaminase polypeptide having a polynucleotide sequence of SEQ ID NO: 17 or SEQ ID NO: 205 is used.

10. The process of claim 1 , comprising the steps of:

a) Mixing 3,4-dimethoxyphenyl ethanol with zinc chloride, diisopropylethylamine and pyrrolidine in toluene;

b) Adding 2-chlorocyclohexanone to obtain a mixture;

c) Adding aqueous hydrochloric acid and discarding the aqueous layer to obtain 2-(3,4-dimethoxyphenyl ethoxy)-cyclohexanone;

d) Adding PLP to a slurry of a transaminase polypeptide having SEQ ID NO: 18 or SEQ ID NO: 206, in sodium tetraborate and isopropylamine to produce a solution;

e) Mixing 2-(3,4-dimethoxyphenyl ethoxy)-cyclohexanone with the solution of step d);

f) Adding a mixture of IPA and MTBE to create a biphasic mixture and discarding the aqueous layer;

g) Performing a solvent switch on the organic layer from the mixture of IPA and MTBE to a fourth solvent, which is selected from sec-butanol or isopropanol, to obtain a solution;

h) Adding a solution of maleic acid in a fourth solvent to the solution of step g) to obtain 2-(3,4-dimethoxyphenylethoxy)-cyclohexylammonium maleate;

i) Mixing 2-(3,4-dimethoxyphenylethoxy)-cyclohexylammonium maleate with a first solvent and a basic aqueous solution and discarding the aqueous layer to obtain 2-(3,4-dimethoxyphenylethoxy)-cyclohexylamine;

j) Adding R-acetoxy malic acid anhydride to 2-(3,4-dimethoxyphenylethoxy)-cyclohexylamine;

k) Adding acetyl chloride;

1 ) Adding the fourth solvent, which is selected from ethanol or isopropanol, to obtain 1 -{2-[2-(3,4-dimethoxyphenyl)-ethoxy]-cyclohexyl}-3-hydroxypyrrolidine-2,5-dione;

m) Mixing 1-{2-[2-(3,4-dimethoxyphenyl)-ethoxy]-cyclohexyl}-3-hydroxypyrrolidine-2,5-dione with sodium borohydride, trimethylborate and an acid, which is selected from BF 3 OEt 2 or BF 3 THF, in THF;

n) Adding water;

o) Adding a basic aqueous solution, which is selected from sodium hydroxide or ammonia, and IPAc, to obtain a biphasic mixture and discarding the aqueous layer to obtain

 and

p) Adding hydrochloric acid to obtain the salt of Compound A.

11. The process of claim 10 , which further comprises in step e), mixing 2-(3,4-dimethoxyphenyl ethoxy)-cyclohexanone in a second solvent, which is selected from DMSO, ethanol or isopropanol, with the solution of step d).

12. The process of claim 1 , comprising the steps of:

a) Mixing a substituted ethanol (ii)

 where Y is selected from 3,4-dimethoxyphenyl, 3,4-dihydroxyphenyl or a 3,4-dihalophenyl, with a zinc salt, a secondary amine and an organic base in a first solvent;

b) Adding a solution of a substituted cycloalkanone (i)

 where R 1 is an activated leaving group and integer n is 2, to obtain a mixture;

c) Adding an acidic aqueous solution and discarding the aqueous phase to obtain an alkoxy ketone (iii)

d) Mixing a co-factor with a slurry of a transaminase polypeptide in a basic buffer and a primary amine to produce a solution;

e) Adding the alkoxy ketone (iii) in a second solvent to the solution of step d);

f) Adding a third solvent to create a biphasic mixture and discarding the aqueous layer;

g) Washing the organic layer from step f) with a basic aqueous solution and discarding the aqueous layer;

h) Performing a solvent switch from the third solvent to a fourth solvent;

i) Adding D-malic acid in a fourth solvent to obtain cyclohexyl amine D-malate salt (iv-c)

j) Mixing the cyclohexyl amine D-malate salt (iv-c) with a sixth solvent and adding a catalytic amount of an acid activator;

k) Adding HMDS and a Lewis acid to obtain hydroxy succinimide (vi)

l) Mixing a metal hydride, an additive and an acid, which is selected from a Lewis acid or a protic acid, with a solution of the isolated hydroxy succinimide (vi);

m) Adding a fifth solvent and a basic aqueous solution to obtain a biphasic mixture and discarding the aqueous layer to obtain Compound A

 and

n) Adding an acid to obtain the salt of Compound A.

13. The process of claim 12 , where the cyclohexyl amine D-malate salt (iv-c)

is isolated as the crystalline form.

14. The process of claim 12 , where a transaminase polypeptide having an amino acid sequence of SEQ ID NO: 18 or SEQ ID NO: 206 is used.

15. The process of claim 12 , comprising the steps of:

a) Mixing 3,4-dimethoxyphenyl ethanol with zinc chloride, diisopropylethylamine and pyrrolidine in toluene;

b) Adding 2-chlorocyclohexanone to obtain a mixture;

c) Adding aqueous hydrochloric acid and discarding the aqueous layer to obtain 2-(3,4-dimethoxyphenyl ethoxy)-cyclohexanone;

d) Adding PLP to a slurry of a transaminase polypeptide having SEQ ID NO: 206, in sodium tetraborate and isopropylamine to produce a solution;

e) Mixing 2-(3,4-dimethoxyphenyl ethoxy)-cyclohexanone with the solution of step d);

f) Adding a mixture of IPA and MTBE to create a biphasic mixture and discarding the aqueous layer;

g) Performing a solvent switch on the organic layer from the mixture of IPA and MTBE to a fourth solvent, which is selected from sec-butanol or isopropanol, to obtain a solution;

h) Adding a solution of D-malic acid in a fourth solvent to the solution of step g) to obtain 2-(3,4-dimethoxyphenylethoxy)-cyclohexylammonium malate;

i) Mixing 2-(3,4-dimethoxyphenylethoxy)-cyclohexylammonium malate with an ester solvent and adding a catalytic amount of an alkyl boronic acid;

j) Heating to about 90 to about 125° C., then cooling to about 70° C.;

k) Adding HMDS and a Lewis acid to obtain 1-{2-[2-(3,4-dimethoxyphenyl)-ethoxy]-cyclohexyl}-3-hydroxypyrrolidine-2,5-dione, where said Lewis acid is zinc chloride, iron(II) chloride, lithium chloride, copper(II) trifluoromethanesulfonate, iron(III) chloride, iron(II) bromide, zinc bromide, zinc acetate or zinc trifluoromethanesulfonate;

l) Mixing 1-{2-[2-(3,4-dimethoxyphenyl)-ethoxy]-cyclohexyl}-3-hydroxypyrrolidine-2,5-dione with sodium borohydride, trimethylborate and an acid, which is selected from BF 3 OEt 2 or BF 3 THF, in THF;

m) Adding water;

n) Adding a basic aqueous solution, which is selected from sodium hydroxide or ammonia, and IPAc, to obtain a biphasic mixture and discarding the aqueous layer to obtain

 and

o) Adding hydrochloric acid to obtain the salt of Compound A.

16. The process of claim 15 , where the alkyl boronic acid is methyl boronic acid or butyl boronic acid.

17. The process of claim 15 , where the Lewis acid in step k) is zinc chloride.

18. The process of claim 1 comprising the steps of:

a) Mixing 3,4-dimethoxyphenyl ethanol with zinc chloride, diisopropylethylamine and pyrrolidine in toluene;

b) Adding 2-chlorocyclohexanone to obtain a mixture;

c) Adding aqueous hydrochloric acid and discarding the aqueous layer to obtain 2-(3,4-dimethoxyphenyl ethoxy)-cyclohexanone;

d) Adding PLP to a slurry of a transaminase polypeptide, said transaminase polypeptide having SEQ ID NO: 18 or SEQ ID NO: 206, in sodium tetraborate and isopropylamine to produce a solution;

e) Mixing 2-(3,4-dimethoxyphenyl ethoxy)-cyclohexanone with the solution of step d);

f) Adding a mixture of IPA and MTBE to create a biphasic mixture and discarding the aqueous layer;

g) Performing a solvent switch on the organic layer from the mixture of IPA and MTBE to a fourth solvent, which is selected from sec-butanol or isopropanol, to obtain a solution;

h) Adding a solution of oxalic acid in the fourth solvent, which is selected from sec-butanol or isopropanol, to the solution of step g to obtain 2-(3,4-dimethoxyphenylethoxy)-cyclohexylammonium oxalate iv-b;

i) Adding 2-(3,4-dimethoxyphenylethoxy)-cyclohexylammonium oxalate iv-b to a mixture of DMAc and potassium bicarbonate followed by (R)-1,4-dibromo-butan-2-ol;

j) Adding IPAc and a basic aqueous solution to obtain a biphasic mixture and discarding the aqueous layer to obtain

 and

k) Adding hydrochloric acid to obtain the salt of Compound A.

Assignments (7)
CHANGE OF NAME Recorded Sep 10, 2018
From: CARDIOME INTERNATIONAL AG
To: CARDIOME INTERNATIONAL SA
Reel/Frame 046832/0090 →
MERGER Recorded Sep 10, 2018
From: CARDIOME INTERNATIONAL SA
To: CORREVIO INTERNATIONAL SÀRL
Reel/Frame 046832/0161 →
RELEASE OF SECURITY INTEREST Recorded Jun 20, 2016
From: MIDCAP FINANCIAL TRUST
To: CARDIOME PHARMA CORP.; CARDIOME, INC.; ARTESIAN THERAPEUTICS, INC.; MURK ACQUISITION SUB, INC.; CORREVIO LLC; CARDIOME INTERNATIONAL AG; CORREVIO INTERNATIONAL SARL; CORREVIO (UK) LTD.; CARDIOME UK LIMITED; CORREVIO (AUSTRALIA) PTY LTD.
Reel/Frame 038961/0202 →
SECURITY INTEREST Recorded Jul 24, 2014
From: CARDIOME PHARMA CORP.; CARDIOME, INC.; ARTESIAN THERAPEUTICS, INC.; MURK ACQUISITION SUB, INC.; CORREVIO LLC; CARDIOME INTERNATIONAL AG; CORREVIO INTERNATIONAL SARL; CORREVIO (UK) LTD.; CARDIOME UK LIMITED; CORREVIO (AUSTRALIA) PTY LTD.
To: MIDCAP FUNDING V, LLC
Reel/Frame 033407/0314 →
CHANGE OF NAME Recorded Apr 21, 2014
From: CARDIOME DEVELOPMENT AG
To: CARDIOME INTERNATIONAL AG
Reel/Frame 032722/0941 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 4, 2013
From: LIMANTO, JOHN; BEUTNER, GREGORY L.; YIN, JINGJUN; KLAPARS, ARTIS; ASHLEY, ERIC R.; STROTMAN, HALLENA R.; TRUPPO, MATTHEW D.; CHUNG, CHEOL K.; HUGHES, GREGORY; LIU, ZHIJIAN; GRAU, BRENDAN; JANEY, JACOB
To: MERCK SHARP & DOHME CORP.
Reel/Frame 031349/0318 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 4, 2013
From: MERCK SHARP & DOHME CORP.
To: CARDIOME DEVELOPMENT AG
Reel/Frame 031350/0032 →
Continuity (3)
Provisional Application 61373966 · Aug 16, 2010
Provisional Application 61510213 · Jul 21, 2011
Related Publication 20130149751A1 · Jun 13, 2013